Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Recruiting

Phase 2

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Sponsor:

Evon Medics LLC

Code:

NCT04850664

Conditions

Opioid Use Disorder, Moderate

Opioid Use Disorder, Severe

Withdrawal Symptoms

Craving

Negative Affectivity

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

CBOT + TAU

Sham + TAU

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Evon Medics LLC on 2021-08-06.